Insulet | PODD - Market Capitalization


Insulet reported $9.33B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 158.05B 20.36B Jun/2026
Align Technology USD 12.08B 198M Jun/2026
AtriCure USD 1.42B 28M Jun/2026
Baxter International USD 11.01B 2.34B Jun/2026
Becton, Dickinson and Co. USD 44.77B 10.52B Mar/2026
Boston Scientific USD 63.44B 29.82B Jun/2026
Cardinal Health USD 49.72B 894M Mar/2026
Cooper Companies USD 12.27B 3.68B Mar/2026
Dexcom USD 25.99B 1.82B Jun/2026
Edwards Lifesciences USD 52.09B 5.92B Jun/2026
Eli Lilly USD 1.09T 37.2B Aug/2026
Globus Medical USD 11.69B 2M Mar/2026
Insulet USD 11.66B 1.12B Aug/2026
Integra LifeSciences USD 1.4B 664M Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Merit Medical Systems USD 4.14B 25M Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Stryker USD 120.7B 5.15B Jun/2026
Teleflex USD 5.3B 99M Mar/2026
West Pharmaceutical Services USD 25.36B 7.3B Jun/2026
WK Kellogg Co USD 15.19B 3.87B Aug/2026
Zimmer Biomet Holdings USD 19.69B 3.03B Aug/2026